Alcohol consumption, Aldehyde dehydrogenase 2 gene polymorphisms, and cardiovascular health in Korea

Min-Jeong Shin, Yoonsu Cho, George Davey Smith

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Alcohol consumption is a serious health issue in Korea in terms of the amount consumed and the behavior related to its consumption. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism that degrades acetaldehyde to nontoxic acetic acid. The enzyme is coded by the ALDH2 gene, which is commonly polymorphic in East Asian populations. A point mutation in the ALDH2 gene (the rs671 allele) yields an inactive form of ALDH2 that causes acetaldehyde accumulation in the body after alcohol consumption, thereby inhibiting normal alcohol metabolism. Individuals who are homozygous for polymorphism in ALDH2 tend to refrain from drinking alcohol, decreasing their chances of developing alcoholism and exposure to the associated risks. Mendelian randomization (MR) studies have demonstrated that alcohol consumption predicted by ALDH2 genotype is causally related to cardiovascular risks. Moreover, recent MR studies suggest that the ALDH2 variant has mechanistic effects on some disease outcomes or mortality through increased blood levels of acetaldehyde, showing differences therein between heterozygotes (ALDH2*2*2) and homozygotes (ALDH2*1*2) in those who consume alcohol. Accordingly, consideration of ALDH2 genotype in alcohol prevention programs is warranted. In conclusion, strategies that incorporate genetic information and provide an evidential basis from which to help people make informed decisions on alcohol consumption are urgently required.

Original languageEnglish
Pages (from-to)689-696
Number of pages8
JournalYonsei Medical Journal
Volume58
Issue number4
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Aldehyde Dehydrogenase
Korea
Alcohol Drinking
Health
Genes
Acetaldehyde
Alcohols
Random Allocation
Genotype
Homozygote
Enzymes
Heterozygote
Point Mutation
Acetic Acid
Alcoholism
Alleles
Mortality

Keywords

  • Alcohol
  • Aldehyde dehydrogenase 2
  • Guidelines
  • Mendelian randomization analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Alcohol consumption, Aldehyde dehydrogenase 2 gene polymorphisms, and cardiovascular health in Korea. / Shin, Min-Jeong; Cho, Yoonsu; Davey Smith, George.

In: Yonsei Medical Journal, Vol. 58, No. 4, 01.07.2017, p. 689-696.

Research output: Contribution to journalReview article

@article{155dc40a36d14146a120c785592da1e1,
title = "Alcohol consumption, Aldehyde dehydrogenase 2 gene polymorphisms, and cardiovascular health in Korea",
abstract = "Alcohol consumption is a serious health issue in Korea in terms of the amount consumed and the behavior related to its consumption. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism that degrades acetaldehyde to nontoxic acetic acid. The enzyme is coded by the ALDH2 gene, which is commonly polymorphic in East Asian populations. A point mutation in the ALDH2 gene (the rs671 allele) yields an inactive form of ALDH2 that causes acetaldehyde accumulation in the body after alcohol consumption, thereby inhibiting normal alcohol metabolism. Individuals who are homozygous for polymorphism in ALDH2 tend to refrain from drinking alcohol, decreasing their chances of developing alcoholism and exposure to the associated risks. Mendelian randomization (MR) studies have demonstrated that alcohol consumption predicted by ALDH2 genotype is causally related to cardiovascular risks. Moreover, recent MR studies suggest that the ALDH2 variant has mechanistic effects on some disease outcomes or mortality through increased blood levels of acetaldehyde, showing differences therein between heterozygotes (ALDH2*2*2) and homozygotes (ALDH2*1*2) in those who consume alcohol. Accordingly, consideration of ALDH2 genotype in alcohol prevention programs is warranted. In conclusion, strategies that incorporate genetic information and provide an evidential basis from which to help people make informed decisions on alcohol consumption are urgently required.",
keywords = "Alcohol, Aldehyde dehydrogenase 2, Guidelines, Mendelian randomization analysis",
author = "Min-Jeong Shin and Yoonsu Cho and {Davey Smith}, George",
year = "2017",
month = "7",
day = "1",
doi = "10.3349/ymj.2017.58.4.689",
language = "English",
volume = "58",
pages = "689--696",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "4",

}

TY - JOUR

T1 - Alcohol consumption, Aldehyde dehydrogenase 2 gene polymorphisms, and cardiovascular health in Korea

AU - Shin, Min-Jeong

AU - Cho, Yoonsu

AU - Davey Smith, George

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Alcohol consumption is a serious health issue in Korea in terms of the amount consumed and the behavior related to its consumption. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism that degrades acetaldehyde to nontoxic acetic acid. The enzyme is coded by the ALDH2 gene, which is commonly polymorphic in East Asian populations. A point mutation in the ALDH2 gene (the rs671 allele) yields an inactive form of ALDH2 that causes acetaldehyde accumulation in the body after alcohol consumption, thereby inhibiting normal alcohol metabolism. Individuals who are homozygous for polymorphism in ALDH2 tend to refrain from drinking alcohol, decreasing their chances of developing alcoholism and exposure to the associated risks. Mendelian randomization (MR) studies have demonstrated that alcohol consumption predicted by ALDH2 genotype is causally related to cardiovascular risks. Moreover, recent MR studies suggest that the ALDH2 variant has mechanistic effects on some disease outcomes or mortality through increased blood levels of acetaldehyde, showing differences therein between heterozygotes (ALDH2*2*2) and homozygotes (ALDH2*1*2) in those who consume alcohol. Accordingly, consideration of ALDH2 genotype in alcohol prevention programs is warranted. In conclusion, strategies that incorporate genetic information and provide an evidential basis from which to help people make informed decisions on alcohol consumption are urgently required.

AB - Alcohol consumption is a serious health issue in Korea in terms of the amount consumed and the behavior related to its consumption. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism that degrades acetaldehyde to nontoxic acetic acid. The enzyme is coded by the ALDH2 gene, which is commonly polymorphic in East Asian populations. A point mutation in the ALDH2 gene (the rs671 allele) yields an inactive form of ALDH2 that causes acetaldehyde accumulation in the body after alcohol consumption, thereby inhibiting normal alcohol metabolism. Individuals who are homozygous for polymorphism in ALDH2 tend to refrain from drinking alcohol, decreasing their chances of developing alcoholism and exposure to the associated risks. Mendelian randomization (MR) studies have demonstrated that alcohol consumption predicted by ALDH2 genotype is causally related to cardiovascular risks. Moreover, recent MR studies suggest that the ALDH2 variant has mechanistic effects on some disease outcomes or mortality through increased blood levels of acetaldehyde, showing differences therein between heterozygotes (ALDH2*2*2) and homozygotes (ALDH2*1*2) in those who consume alcohol. Accordingly, consideration of ALDH2 genotype in alcohol prevention programs is warranted. In conclusion, strategies that incorporate genetic information and provide an evidential basis from which to help people make informed decisions on alcohol consumption are urgently required.

KW - Alcohol

KW - Aldehyde dehydrogenase 2

KW - Guidelines

KW - Mendelian randomization analysis

UR - http://www.scopus.com/inward/record.url?scp=85019771709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019771709&partnerID=8YFLogxK

U2 - 10.3349/ymj.2017.58.4.689

DO - 10.3349/ymj.2017.58.4.689

M3 - Review article

C2 - 28540979

AN - SCOPUS:85019771709

VL - 58

SP - 689

EP - 696

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 4

ER -